FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Valeant Pharmaceuticals North America Virazole Recall

Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administrati…

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Jan 28, 2015
Recall ID
D-0379-2015
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Virazole starting Dec 31, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0379-2015 on Jan 28, 2015. Reason: Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull. Status: Terminated.

Why it was recalled

Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

Product description

Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.

Lot numbers, UPCs & expiration codes

Lot #: 340353F, Exp 10/2018

Where it was sold

Nationwide and Australia

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0379-2015
Classification
Class II
Status
Terminated
Recall initiated
Dec 31, 2014
FDA report date
Jan 28, 2015
Quantity
2,428 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-0379-2015, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
70123
Address
400 Somerset Corporate Blvd
Code information
Lot #: 340353F, Exp 10/2018
Postal code
08807
Report date
Jan 28, 2015
Product type
Drugs
Recall number
D-0379-2015
Classification
Class II
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
2,428 vials
Termination date
Oct 4, 2017
Reason for recall
Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.
Distribution pattern
Nationwide and Australia
Recall initiation date
Dec 31, 2014
Initial firm notification
Press Release
Center classification date
Jan 22, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0379-2015, published Jan 28, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls